BerandaASRT • NASDAQ
add
Assertio Holdings Inc
Tutup sebelumnya
$0,64
Rentang hari
$0,65 - $0,68
Rentang tahun
$0,51 - $1,80
Kapitalisasi pasar
64,81Â jt USD
Volume Rata-Rata
227,10Â rb
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Dalam berita
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 26,49Â jt | -18,37% |
Biaya operasional | 31,65Â jt | 27,15% |
Laba bersih | -13,54Â jt | -200,24% |
Margin laba bersih | -51,12 | -267,77% |
Penghasilan per saham | -0,04 | -200,00% |
EBITDA | -3,68Â jt | -276,77% |
Tarif pajak efektif | -1,84% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 87,32Â jt | 8,15% |
Total aset | 286,43Â jt | 1,58% |
Total liabilitas | 177,90Â jt | 20,63% |
Total ekuitas | 108,53 jt | — |
Saham yang beredar | 95,78 jt | — |
Harga terhadap nilai buku | 0,57 | — |
Tingkat pengembalian aset | -11,33% | — |
Tingkat pengembalian modal | -20,87% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -13,54Â jt | -200,24% |
Kas dari operasi | -12,54Â jt | -267,00% |
Kas dari investasi | -2,94 jt | — |
Kas dari pembiayaan | -111,00Â rb | 46,12% |
Perubahan kas bersih | -15,58Â jt | -313,42% |
Arus kas bebas | -7,64Â jt | -182,12% |
Tentang
Assertio Therapeutics, Inc. is an American specialty pharmaceutical company. It mainly markets products for treatment in neurology, pain and diseases of the central nervous system. Depomed was founded in 1995 and is headquartered in Newark, California. It is a publicly traded company on NASDAQ, with several products approved by the United States Food and Drug Administration. On August 15, 2018, the company announced its name change from Depomed, Inc., to Assertio Therapeutics, Inc. As of 2019, Assertio markets three products approved by the FDA: Gralise, Cambia, and Zipsor. Wikipedia
Didirikan
1995
Kantor pusat
Situs
Karyawan
58
